Founded by three senior bankers from top investment banks in the world, Tririver Capital is a leading boutique investment bank in China, which focuses on small and mid-sized bio-health care companies.
        Our business includes Private Placement, Mergers and Acquisitions, Partnering & licensing and Asset Management of Angel fund and Venture Capital Fund. We focus on bio-techs, pharmaceuticals, medical devices, medical services, and new materials etc. We provide services to clients at all stages, from early stage, growth stage, to pre-IPO stage. We are one of the very few banks which can provide one-stop advisory service to early-stage clients.
        As the first bio-health care- only investment bank in China, we have the most experience, and best information and resources in bio-health care science sectors among our rivals. Since 2010, we have been the No.1 bank in bio- health care sector, by number of clients and closed transactions.